1067581

Ashwani K. Singal, M.D. — FEI 3014617662

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 28, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Vestavia Hills, AL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance